Long-Term Management of Prolactinomas—Use of Long-Acting Dopamine Agonists

Author： Cook David  

Publisher： Springer Publishing Company

ISSN： 1389-9155

Source： Reviews in Endocrine and Metabolic Disorders, Vol.6, Iss.1, 2005-01, pp. : 15-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Acting -Agonists: Comparative Pharmacology and Clinical Outcomes

By van der Woude H.J.   Aalbers R.  

American Journal of Respiratory Medicine, Vol. 1, Iss. 1, 2002-01 ,pp. : 55-74

Adis International

Access to resources Recommend Favorite

Use of Long-Acting β-Agonists and Inhaled Steroids in Asthma: Meta-analysis of Observational Studies

By Hirst Ceri   Calingaert Brian   Stanford Richard   Castellsague Jordi  

Journal of Asthma, Vol. 47, Iss. 4, 2010-05 ,pp. : 439-446

Informa Healthcare

Access to resources Recommend Favorite

Long-Acting Beta-Agonists and the Risk of Intensive Care Unit Admission in Children

By Jacobs Tammy S.   Jones Bobby L.   MacGinnitie Andrew J.  

Journal of Asthma, Vol. 49, Iss. 5, 2012-06 ,pp. : 450-455

Informa Healthcare

Access to resources Recommend Favorite

Combination Therapy of Long-Acting  2 -Adrenoceptor Agonists and Corticosteroids for Asthma

By Chung K. Fan  

Treatments in Respiratory Medicine, Vol. 3, Iss. 5, 2004-01 ,pp. : 279-289

Adis International

Access to resources Recommend Favorite

Long-term Efficacy of Bromocriptine in Macroprolactinomas and Giant prolactinomas in Men

By Chattopadhyay Arijit   Bhansali Anil   Masoodi Shariq  

Pituitary, Vol. 8, Iss. 2, 2005-04 ,pp. : 147-154

Springer Publishing Company

Access to resources Recommend Favorite